Form D · Pharmaceuticals

AERIAL BIOPHARMA, LLC

Morrisville, NC · CIK 0001532417

Offering snapshot reported Oct 9, 2013 · SEC filing

Reported sold
$9.5M
Offering amount: $12M
Investors reported
31
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 11, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.75M$9.5MOct 11, 2011Oct 11, 2012: $5,664,618.00Oct 11, 2012Oct 9, 2013: $9,500,000.00Oct 9, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$5,664,618 → $9,500,000
  • Reported investors23 → 31

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 9, 2013Amendment$9,500,000$3,835,382vs Oct 11, 201231SEC filing
Oct 11, 2012Amendment$5,664,618No comparison23SEC filing
Oct 11, 2011InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-167025

Source: Form D, filed Oct 9, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Adair Director
Gary Bream Director, Executive
Stephen Butts Director, Executive
Moise Khayrallah Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
9001 Aerial Center Parkway, Suite 110
Morrisville, NC, 27560